Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Corvex Capital Increases Stake in Williams Companies Inc. (WMB)

Keith Meister’s Corvex Capital, in a filing revealed that it owns 46.10 million shares of Williams Companies, Inc. (NYSE:WMB), representing 6.74% of the Common Stock of the company. This position was raised from some 36.09 million shares held earlier.

Earlier, in December, Corvex Capital signed an agreement with Eric W. Mandelblatt’s Soroban Capital Partners, to mutually take decisions related to of Williams Companies, Inc. (NYSE:WMB)’s nomination of directors, management, other corporate matters and various other issues of the company. Corvex Capital and Soroban Capital Partners are the largest shareholders of the company.

Keith Meister

Williams Companies, Inc. (NYSE:WMB) deals in energy infrastructure. In December, Williams Companies, Inc. (NYSE:WMB) succeeded to meat the increased demand due to the cold weather, and delivered a record amount of natural gas on its Transco interstate gas pipeline, attributing the achievement to the successful completion of the Pipeline Expansions, which helped increase the capacity by 475,000 dekatherms per day, the company said in a statement.

The stock of Williams Companies, Inc. (NYSE:WMB) has gained around 16% over the past year, trailing a P/E of 43.6x.

Another fund bullish on the stock is Jeffrey Tannenbaum’s Fir Tree, which holds 7.52 million shares of the company, according to its latest 13F.

Corvex Capital, raised its stake in Fidelity National Financial Inc (NYSE:FNF) to 18.2 million shares from 17.4 million shares. While the fund, reduced its stake in ADT Corp (NYSE:ADT), to 361,585 shares by selling 10.24 million shares for a price of $44.01 per share. Earlier, in November end, the fund had trimmed its stake in ADT Corp to 10.6 million shares from 11.2 million shares.

Disclosure: none

Recommended Reading:

Jana Partners Boosts its Exposure to QEP Resources Inc (QEP)

Sandell Asset Management Files Complaint Against Bob Evans Farms Inc (BOBE)

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!